NCT00639639View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 6, 2006

Primary Completion Date

April 15, 2017

Study Completion Date

June 1, 2022

Conditions
Malignant Neoplasms of Brain
Interventions
BIOLOGICAL

tetanus toxoid

Given by injection

BIOLOGICAL

therapeutic autologous dendritic cells

Given intradermally

BIOLOGICAL

therapeutic autologous lymphocytes

Given IV

Trial Locations (1)

27710

Duke University Medical Center, Durham

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gary Archer Ph.D.

OTHER

NCT00639639 - Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter